Orion Biotechnology lands $11.5m in Keiretsu-led Series A

Ottawa-based biotechnology startup Orion Biotechnology Canada has secured $11.5 million in a Series A financing.

18 June 2021•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.